CompletedPHASE2, PHASE3NCT06333834
Assessment of the Efficacy of Scorpion Antivenom Therapy in a Dose-response Manner, in Patients With Scorpionism
Studying Scorpion envenomation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Selene Guadalupe Huerta Olvera
- Principal Investigator
- Selene G Huerta-Olvera, PhDMedical & Life Sciences Department. La Ciénega University Center
- Intervention
- Traditional scorpion antivenom regimen(drug)
- Enrollment
- 56 target
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- Servicios Médicos Municipales de San Pedro Tlaquepaque., Tlaquepaque, Jalisco, Mexico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06333834 on ClinicalTrials.gov